Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine for rectal hypersensitivity in irritable bowel syndrome
NL-OMON22721Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Fexofenadine with Placebo (2 arms). Primary endpoint: Effect of fexofenadine on rectal sensitivity. Planned start Dec 2008; status: not yet recruiting.
02
Drugs
fexofenadine
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NL-OMON22721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22721.